av/natco-pharma--big.svg

NSE:NATCOPHARM

NATCO Pharma

  • Stock

INR

Last Close

850.90

02/05 08:51

Market Cap

212.46B

Beta: 0.42

Volume Today

426.14K

Avg: 330.36K

PE Ratio

13.65

PFCF: -

Dividend Yield

1.11%

Payout:0%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
Mar '25
average inventory
2.01B
-
2.89B
43.92%
3.53B
22.33%
3.94B
11.49%
4.84B
22.88%
5.43B
12.36%
6.78B
24.77%
7.80B
15.04%
7.52B
3.54%
7.67B
1.97%
7.79B
1.49%
average payables
1.18B
-
639.28M
45.61%
22.78M
96.44%
34M
49.27%
1.11B
3,161.76%
2.36B
112.98%
2.01B
14.99%
1.54B
23.31%
2.13B
38.18%
2.50B
17.32%
2.55B
2.22%
average receivables
1.81B
-
2.92B
61.96%
4.49B
53.38%
6.22B
38.65%
7.01B
12.73%
3.43B
51.11%
2.35B
31.36%
5.71B
142.58%
7.69B
34.66%
10.22B
33.03%
12.62B
23.45%
book value per share
51.09
-
76.17
49.09%
94.66
24.28%
173.26
83.03%
189.41
9.32%
207.41
9.50%
226.26
9.09%
233.75
3.31%
266.96
14.21%
326.07
22.14%
capex per share
-7.20
-
-9.23
28.26%
-16.04
73.76%
-23.93
49.16%
-25.06
4.74%
-19.71
21.36%
-13.98
29.09%
-13.31
4.80%
-11.26
15.36%
18.91
267.89%
capex to depreciation
-2.52
-
-3.09
22.46%
-5.14
66.35%
-6.41
24.75%
-5.70
11.07%
-3.59
36.96%
-2.18
39.39%
-1.70
21.85%
-1.26
26.25%
1.82
244.75%
1.71
6.14%
capex to operating cash flow
-1.29
-
-1.54
19.49%
-0.81
47.42%
-0.92
13.23%
-0.69
24.57%
-0.86
24.48%
-0.85
0.84%
-5.22
512.55%
-0.24
95.36%
0.28
215.69%
0.22
21.72%
capex to revenue
-0.15
-
-0.14
3.93%
-0.14
2.06%
-0.20
43.59%
-0.22
13.82%
-0.19
15.17%
-0.15
20.71%
-0.13
15.41%
-0.08
40.39%
0.08
211.66%
0.09
6.77%
cash per share
0.76
-
3.82
403.03%
7.87
106.41%
47.73
506.09%
57.41
20.29%
49.61
13.60%
44.48
10.34%
41.66
6.33%
63.65
52.79%
99.06
55.62%
days of inventory on hand
283.50
-
331.72
17.01%
183.50
44.68%
314.44
71.35%
418.02
32.94%
399.35
4.47%
479.26
20.01%
408.11
14.85%
432.26
5.92%
335.04
22.49%
183.95
45.09%
days payables outstanding
161.47
-
2.37
98.53%
1.05
55.66%
3.44
227.29%
171.48
4,880.84%
182.79
6.60%
87.78
51.98%
86.66
1.28%
153.49
77.13%
99.66
35.07%
66.03
33.74%
days sales outstanding
95.89
-
120.02
25.16%
94.35
21.39%
121.28
28.54%
121.37
0.08%
101.62
-
128.57
26.52%
116.80
9.15%
108.43
7.17%
103.50
4.55%
debt to assets
0.23
-
0.06
72.74%
0.10
54.99%
0.05
51.24%
0.09
92.56%
0.07
20.02%
0.06
17.48%
0.08
42.72%
0.03
65.15%
0.05
85.80%
0.03
40.87%
debt to equity
0.37
-
0.09
76.59%
0.13
55.04%
0.06
58.04%
0.11
96.39%
0.09
21.16%
0.07
21.09%
0.10
47.10%
0.03
66.24%
0.06
88.87%
0.04
43.14%
dividend yield
0.00
-
0.00
29.86%
0.01
156.97%
0.01
39.26%
0.01
19.75%
0.02
56.92%
0.01
54.65%
0.01
21.31%
0.01
63.80%
0.01
0.10%
earnings yield
0.02
-
0.02
14.46%
0.03
48.91%
0.05
54.95%
0.06
21.60%
0.05
19.06%
0.03
41.48%
0.01
57.96%
0.07
464.26%
0.08
14.21%
enterprise value
72.86B
-
71.03B
2.51%
149.93B
111.09%
138.29B
7.76%
107.69B
22.13%
95.07B
11.72%
152.96B
60.89%
141.13B
7.73%
103.20B
26.88%
177.94B
72.43%
-18.97B
110.66%
enterprise value over ebitda
32.44
-
24.62
24.12%
20.79
15.53%
14.26
31.40%
11.83
17.06%
14.08
19.00%
22.33
58.63%
42.26
89.23%
9.92
76.52%
9.47
4.57%
-0.74
107.85%
ev to operating cash flow
78.62
-
69.38
11.76%
43.36
37.50%
29.83
31.20%
16.10
46.02%
22.78
41.49%
51.19
124.70%
303.51
492.89%
12.15
96.00%
14.69
20.84%
-1.04
107.06%
ev to sales
8.90
-
6.31
29.05%
7.35
16.40%
6.41
12.76%
5.22
18.54%
5.04
3.58%
9.05
79.69%
7.41
18.13%
3.81
48.55%
4.45
16.64%
-0.43
109.63%
free cash flow per share
-1.60
-
-3.23
101.28%
3.81
217.95%
2.22
41.76%
11.24
407.26%
3.23
71.30%
2.43
24.79%
-10.76
543.30%
35.25
427.69%
47.51
34.80%
free cash flow yield
-0.00
-
-0.01
105.71%
0.00
157.32%
0.00
35.88%
0.02
592.32%
0.01
67.92%
0.00
53.95%
-0.01
583.98%
0.06
539.83%
0.05
22.01%
graham net net
-15.04
-
0.03
100.20%
2.46
8,046.03%
54.36
2,106.32%
55.60
2.29%
20.80
62.59%
49.06
135.90%
43.78
10.76%
310.20
608.47%
112.11
63.86%
graham number
96.67
-
124.91
29.22%
243.75
95.14%
391.24
60.51%
386.12
1.31%
343.80
10.96%
351.03
2.10%
221.40
36.93%
485.12
119.12%
753.26
55.27%
income quality
0.69
-
0.50
28.23%
0.55
11.77%
0.52
5.65%
0.81
55.20%
0.73
9.52%
0.52
29.74%
0.23
55.39%
0.99
328.38%
0.87
11.41%
0.97
11.16%
intangibles to total assets
0.03
-
0.00
85.27%
0.00
48.83%
0.00
26.92%
0.00
36.35%
0.00
5.13%
0.00
2.27%
0.03
1,226.05%
0.03
27.61%
0.03
15.77%
0.03
10.27%
interest coverage
5.64
-
11.14
97.56%
40.97
267.87%
66.33
61.89%
44.32
33.18%
27.75
37.39%
56.93
105.15%
16.66
70.74%
60.44
262.81%
135.22
123.72%
82.04
39.33%
interest debt per share
20.74
-
7.85
62.18%
13.64
73.82%
10.51
22.92%
21.85
107.85%
19.08
12.69%
16.07
15.78%
24.41
51.90%
9.93
59.34%
22.13
123.00%
inventory turnover
1.29
-
1.10
14.54%
1.99
80.77%
1.16
41.64%
0.87
24.78%
0.91
4.68%
0.76
16.67%
0.89
17.43%
0.84
5.59%
1.09
29.02%
1.98
82.13%
invested capital
0.37
-
0.09
76.59%
0.13
55.04%
0.06
58.04%
0.11
96.39%
0.09
21.16%
0.07
21.09%
0.10
47.10%
0.03
66.24%
56.79B
166,030,806,478,604.25%
72.50B
27.67%
market cap
69.85B
-
70.34B
0.71%
147.95B
110.33%
136.78B
7.55%
104.11B
23.88%
91.98B
11.66%
150.38B
63.50%
137.92B
8.28%
102.85B
25.43%
174.79B
69.94%
net current asset value
-500.03M
-
3.12B
723.46%
4.23B
35.72%
14.92B
252.54%
15.35B
2.92%
15.22B
0.82%
16.69B
9.61%
16.52B
1.02%
64.80B
292.34%
29.70B
54.16%
42.52B
43.13%
net debt to ebitda
1.34
-
0.24
82.29%
0.27
15.80%
0.16
43.12%
0.39
151.67%
0.46
16.57%
0.38
17.80%
0.96
154.99%
0.03
96.52%
0.17
402.08%
-0.74
542.71%
net income per share
8.13
-
9.10
11.99%
27.89
206.40%
39.26
40.76%
34.98
10.90%
25.33
27.60%
24.20
4.44%
9.32
61.49%
39.18
320.39%
77.34
97.40%
operating cash flow per share
5.60
-
6.01
7.34%
19.85
230.44%
26.15
31.73%
36.31
38.87%
22.94
36.83%
16.40
28.48%
2.55
84.46%
46.51
1,724.38%
67.50
45.13%
payables turnover
2.26
-
153.84
6,705.59%
347
125.56%
106.02
69.45%
2.13
97.99%
2.00
6.19%
4.16
108.23%
4.21
1.30%
2.38
43.54%
3.66
54.02%
5.53
50.92%
receivables turnover
3.81
-
3.04
20.10%
3.87
27.21%
3.01
22.20%
3.01
0.08%
3.59
-
2.84
20.96%
3.12
10.07%
3.37
7.72%
3.53
4.77%
research and ddevelopement to revenue
0.02
-
0.01
13.01%
0.02
68.32%
0.02
5.00%
0.04
63.92%
0.03
4.51%
0.09
159.89%
0.09
6.57%
0.03
64.12%
0.03
9.18%
return on tangible assets
0.10
-
0.09
15.01%
0.21
145.87%
0.19
10.57%
0.15
20.18%
0.10
32.94%
0.09
8.39%
0.03
62.94%
0.13
282.81%
0.21
58.13%
0.23
8.99%
revenue per share
49.43
-
65.99
33.50%
117.08
77.42%
121.63
3.88%
111.93
7.98%
103.76
7.30%
92.79
10.57%
104.43
12.54%
148.28
41.98%
222.95
50.35%
roe
0.16
-
0.12
24.88%
0.29
146.55%
0.23
23.10%
0.18
18.50%
0.12
33.88%
0.11
12.40%
0.04
62.73%
0.15
268.08%
0.24
61.61%
0.25
4.49%
roic
0.13
-
0.12
5.49%
0.27
118.22%
0.21
22.31%
0.14
31.73%
0.10
33.21%
0.09
9.99%
0.04
54.73%
0.14
267.26%
0.35
139.61%
0.20
41.44%
sales general and administrative to revenue
0.03
-
0.02
23.98%
0.02
16.92%
0.02
5.17%
0.02
41.12%
0.03
24.73%
0.03
7.50%
0.04
28.47%
0.04
8.04%
0.03
27.04%
shareholders equity per share
51.09
-
76.17
49.09%
94.66
24.28%
173.26
83.03%
189.41
9.32%
207.41
9.50%
226.26
9.09%
233.75
3.31%
266.96
14.21%
326.07
22.14%
stock based compensation to revenue
0.01
-
0.01
29.98%
0.01
38.42%
0.01
47.03%
0.01
37.84%
0.01
2.28%
0.00
84.51%
tangible asset value
8.05B
-
12.94B
60.76%
16.48B
27.29%
30.64B
85.98%
34.82B
13.64%
37.76B
8.43%
41.14B
8.95%
41.31B
0.41%
89.50B
116.66%
56.60B
36.76%
73.46B
29.79%
tangible book value per share
48.62
-
75.94
56.19%
94.57
24.53%
172.81
82.74%
189.04
9.39%
207.54
9.78%
225.85
8.82%
226.46
0.27%
490.21
116.47%
315.31
35.68%
working capital
692.26M
-
3.39B
390.28%
4.61B
35.77%
15.39B
233.92%
16.18B
5.19%
16.40B
1.35%
18.12B
10.45%
17.87B
1.37%
23.17B
29.68%
30.51B
31.65%
43.27B
41.82%

All numbers in INR (except ratios and percentages)